Bellevue Group AG (BBN.SW) Stock Analysis & Winston Score

Bellevue Group AG is a Swiss asset management firm that runs investment funds for wealthy individuals and institutional clients like pension funds. The company specializes in healthcare and biotech investing, meaning it pools money from investors and puts it into stocks of hospitals, drug companies, and medical device makers. It is a small, focused player headquartered in Küsnacht, Switzerland. Bellevue makes money by charging fees based on how much money clients have invested with them, plus performance fees when funds beat their targets. It operates mainly across Europe, with some reach into global markets, and its edge comes from deep specialist knowledge in healthcare investing — a niche that is harder for generalist competitors to replicate. The main risk the company faces is that assets under management can shrink quickly if markets fall or clients withdraw funds, which directly cuts revenue since fees are tied to the size of those assets.